tiprankstipranks
Parkway Life Real Estate Investment Trust (SG:C2PU)
SGX:C2PU

Parkway Life Real Estate Investment (C2PU) AI Stock Analysis

55 Followers

Top Page

SG:C2PU

Parkway Life Real Estate Investment

(SGX:C2PU)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - 5.2)
Rating:64Neutral
Price Target:
S$4.50
▲(11.94% Upside)
Action:ReiteratedDate:02/03/26
The score is driven primarily by solid financial performance (re-accelerating revenue growth, moderate leverage, and stable operating cash flow), tempered by inconsistent free cash flow including a reported zero in 2025. Technical indicators are weak/neutral, while valuation is supportive but not compelling enough to offset the cash generation risk.
Positive Factors
Stable rental income from healthcare leases
Concentration in income-producing healthcare properties with long-term leases creates durable, contractually backed cash flows that are defensive versus economic cycles. That predictability supports steady distributions and planning for acquisitions or portfolio maintenance over the medium term.
Negative Factors
Inconsistent free cash flow
Volatile or absent free cash flow undermines the REIT's ability to self-fund distributions, capex and acquisitions without external financing. A zero FCF year raises structural questions about discretionary cash available after maintenance and financing, increasing reliance on capital markets.
Read all positive and negative factors
Positive Factors
Negative Factors
Stable rental income from healthcare leases
Concentration in income-producing healthcare properties with long-term leases creates durable, contractually backed cash flows that are defensive versus economic cycles. That predictability supports steady distributions and planning for acquisitions or portfolio maintenance over the medium term.
Read all positive factors

Parkway Life Real Estate Investment (C2PU) vs. iShares MSCI Singapore ETF (EWS)

Parkway Life Real Estate Investment Business Overview & Revenue Model

Company Description
Parkway Life Real Estate Investment Trust ("PLife REIT") is one of Asia's largest listed healthcare REITs by asset size. It invests in income-producing real estate and real estate related assets that are used primarily for healthcare and healthcar...
How the Company Makes Money
Parkway Life Real Estate Investment generates revenue primarily through rental income from its portfolio of healthcare properties. The company leases its properties to operators of healthcare facilities, who pay rent on a long-term basis, ensuring...

Parkway Life Real Estate Investment Financial Statement Overview

Summary
Solid overall fundamentals: revenue growth re-accelerated in 2025 (+9.2%), leverage is moderate for a REIT with growing equity, and operating cash flow has been stable. Offsetting this, earnings quality appears volatile and free cash flow has been inconsistent, including a reported zero in 2025, which raises concern around cash flexibility.
Income Statement
74
Positive
Balance Sheet
78
Positive
Cash Flow
62
Positive
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue151.16M164.99M144.85M147.47M129.97M120.70M
Gross Profit141.43M134.61M126.74M124.59M107.52M98.43M
EBITDA0.00130.82M113.88M121.20M112.14M100.01M
Net Income83.67M152.79M95.04M100.47M41.14M331.88M
Balance Sheet
Total Assets2.62B2.65B2.55B2.33B2.34B2.35B
Cash, Cash Equivalents and Short-Term Investments49.04M47.77M29.47M28.50M40.01M25.79M
Total Debt927.48M887.54M886.11M828.47M851.89M828.01M
Total Liabilities1.03B982.62M981.20M919.58M931.66M910.43M
Stockholders Equity1.59B1.67B1.57B1.41B1.41B1.43B
Cash Flow
Free Cash Flow0.000.0046.68M77.65M30.74M78.17M
Operating Cash Flow0.0099.49M95.79M108.69M94.63M89.86M
Investing Cash Flow0.00-69.71M-239.93M-49.56M-125.18M-74.99M
Financing Cash Flow0.00-7.17M147.35M-67.92M47.75M-9.98M

Parkway Life Real Estate Investment Technical Analysis

Technical Analysis Sentiment
Positive
Last Price4.02
Price Trends
50DMA
4.01
Negative
100DMA
4.00
Positive
200DMA
4.01
Positive
Market Momentum
MACD
>-0.01
Negative
RSI
52.72
Neutral
STOCH
66.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C2PU, the sentiment is Positive. The current price of 4.02 is above the 20-day moving average (MA) of 3.99, above the 50-day MA of 4.01, and above the 200-day MA of 4.01, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 52.72 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:C2PU.

Parkway Life Real Estate Investment Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
S$3.50B5.06%6.46%1.47%-7.50%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
65
Neutral
S$4.53B8.388.90%7.36%4.22%25.85%
64
Neutral
S$2.62B17.425.23%3.76%2.55%-23.99%
62
Neutral
S$4.43B-0.38%4.55%0.01%-110.22%
58
Neutral
S$497.12M6.63%8.26%-11.43%-39.27%
57
Neutral
S$1.06B-35.89-0.10%5.84%-2.96%-101.38%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SG:C2PU
Parkway Life Real Estate Investment
4.02
0.02
0.60%
SG:K71U
Keppel REIT
0.92
0.16
20.39%
SG:HMN
Ascott Residence
0.91
0.12
15.63%
SG:J85
CDL Hospitality Trusts
0.83
0.12
16.57%
SG:AW9U
First Real Estate Investment
0.24
<0.01
2.13%
SG:T82U
Suntec Real Estate Investment
1.50
0.43
40.19%

Parkway Life Real Estate Investment Corporate Events

Parkway Life REIT Issues New Units for Management Fee Payment
Nov 14, 2025
Parkway Trust Management Limited, the manager of Parkway Life Real Estate Investment Trust, has announced the issuance of 33,901 new units to itself as part payment for management fees. These units, priced at approximately S$4.11 each, cover the b...
Parkway Life REIT Streamlines Structure with Subsidiary Dissolution
Nov 11, 2025
Parkway Life Real Estate Investment Trust has dissolved four of its wholly-owned subsidiaries in France as part of an internal restructuring to streamline its group holding structure. This dissolution is not expected to materially impact the net t...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 03, 2026